Metastatic breast cancer (MBC) rest an incurably disease associated with bad prognosis and a median overall survival of 23–31 months. There are several treatment options including chemotherapy and sometimes endocrine therapy. | Successfully treatment by eribulin in visceral crisis A case of lymphangitic carcinomatosis from metastatic breast cancer